Novavax Medical Information
DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN Italy ONLY.
If you are NOT a Healthcare Professional in Italy, please switch to the Consumer Medical Information page.
Information on the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)
If your enquiry is regarding the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.
Request Medical Information
Healthcare Professionals may request medical information via ONE of the following ways:
Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.
Option 2: Call +39 06 9480 5311 between 09:00–17:00.
Report an Adverse Event (AE)
If you are concerned about an adverse event, it should be reported to the Italian Medicines Agency at www.aifa.gov.it/en/web/guest/home. Alternatively, adverse events of concern in association with NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601) can be reported to Novavax Pharmacovigilance at +39 06 9480 5311 or via the Novavax Adverse Event Reporting Form.
Report a Product Quality Complaint
If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +39 06 9480 5311 between 09:00–17:00.